LISTED medicinal cannabis firm Medlab has delivered the first batch of its cannabis-based medicine NanaBis to Sydney's Royal North Shore Hospital ahead of human trials in advanced cancer pain.
The trial will test the safety, efficacy and dose tolerance of cancer patients with both managed and unmanaged pain, and if successful will form the basis of a NanaBis drug application being put before the TGA and subsequent global regulatory agencies.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 18
